What it means
Acarbose inhibits alpha-glucosidase, the enzyme in the small intestine that breaks starches and sucrose into absorbable sugars. Taken with a meal, it slows carbohydrate absorption, flattening the post-meal glucose peak and pushing more undigested carbohydrate to the colon, where bacteria ferment it into short-chain fatty acids. It is licensed for type 2 diabetes in most countries.
The flip side of the mechanism is the side effect: gas and bloating from the fermentation, which is why many people stop taking it.
Why it matters for longevity
Post-meal glucose excursions are an independent predictor of cardiovascular risk, and the CGM era has made them visible. Acarbose is the cleanest tool for flattening them without affecting fasting glucose, and it is one of only a few drugs with a positive mouse-lifespan result.
What the evidence says
In the NIA Interventions Testing Program, acarbose extended median lifespan in male mice by about 22% when started at four months and by around 11% when started at 16 months; female mice gained less (around 5%). It also lowered fasting glucose and changed the gut microbiome in a direction associated with longevity.
In humans, the STOP-NIDDM trial (2002) showed acarbose reduced progression from prediabetes to diabetes by 25% and cardiovascular events by about half, in 1,400 people over three years. The ACE trial in China (2017, 6,500 people) confirmed the diabetes reduction but not the cardiovascular one. No trial has looked at ageing outcomes in healthy adults.
How to measure or use it
- Prescription-only. The use case is a high post-meal glucose on a CGM or a glucose tolerance test with a normal fasting value.
- Judge it on post-meal peaks (CGM) and HbA1c over three months; gas and bloating are the common reason for stopping, and are worse with more starch.
- The non-drug route to the same effect: fibre and protein before carbohydrate, a walk after meals, and less refined starch.
Related
- The longevity drugs — acarbose next to the other ITP results
- Metabolic health — post-meal glucose and why it matters
- Fasting and time-restricted eating — the dietary route to the same curve
Frequently asked questions
Does acarbose extend human lifespan?
Unknown. It extends male mouse lifespan and reduces diabetes progression in people; no ageing trial in healthy adults exists.
Why did it work better in male mice?
Not established. Sex differences in glucose metabolism and gut microbiome response are the leading explanations.
Can I get the same effect from diet?
Largely. Eating fibre and protein before carbohydrate, limiting refined starch and walking after meals flatten post-meal glucose measurably on a CGM.
Want this applied to your own numbers?
Fifteen minutes of intake, your labs, a human-reviewed protocol within about 24 hours, three documents, a free coach call and check-ins through the cycle. €399, follow-up included.
Build my protocol Book a 15-minute call